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Diplococcus pneumoniae elaborates a heat labile 
substance capable of lysing rabbit erythrocytes in vitro 
and in vivo (Shumway and Pollock, 1965) . It has 
been suggested (Shumway and Pollock, 1965) that 
this substance may be responsible for the hemolytic 
anemia which occurs in rabbits with pneumococcal 
septicemia (Shumway, 1958) but proof for this 
hypothesis is still lacking. 
The purposes of this report are to describe a method 
of preparing a potent crude pneumococcal hemolysin, 
to define some of its characteristics, and to describe 
the effects of its administration to rabbits. 
Methods 
Preparation of Crude Hemolysin 
The microorganism utilized in these studies was a 
strain of Diplococcus pneumoniae, type 1, kindly sup-
plied by Herbert Morgan. As the microorganism 
grows in glucose-enriched brain-heart infusion broth, 
it elaborates a hemolysin which can be precipitated 
from the supernatant broth by ammonium sulfate. 
Because early investigations suggested that the hemoly-
sin was an endotoxin (Cole, 1914), attempts were 
made to extract the hemolytic substance from bacterial 
cells rather than from the supernatant broth. Pre-
liminary studies disclosed that hemolytically active 
extracts could be obtained when the bacteria were 
disrupted enzymatically with lysozyme, osmotically 
with distilled water, or mechanically with glass beads 
or high frequency sound. Sonic disintegration proved 
to be the simplest and most efficient method of cell 
disruption. 
A potent crude hemolysin was prepared in the fol-
lowing manner: Three liters of brain-heart infusion 
broth (Difeo) containing glucose in a final concentra-
tion of 500 mg/ 100 ml was inoculated with 300 ml of 
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a 6 to 8 hr broth culture of Diplococcus pneu-
moniae, type 1. The broth was maintained at 37 C 
in an atmosphere of nitrogen and was mixed con-
tinuously with a magnetic stirrer. Aliquots were with-
drawn at 30 to 60 min intervals to measure turbidity 
at 650 m,u., pH and glucose concentration. The pH, 
which decreased rapidly during the logarithmic phase 
of bacterial growth, was maintained between 7.0 and 
7.5 by the gradual addition of sterile 5N sodium car-
bonate. Glucose concentration was maintained be-
tween 400 and 600 mg/ 100 ml by the addition of 
sterile 50% glucose solution. When the optical density 
of the culture reached its maximum ( 6-8 hr) the 
broth was placed at 4 C under nitrogen for 18 hr. 
It was then centrifuged at 18,000 G in a continuous 
flow system; this centrifugation and all subsequent 
manipulations were carried out at 5 C. 
The sedimented bacteria were suspended in approx-
imately two volumes of cold distilled water and sub-
jected to high frequency sound (Branson Model S-75 
Sonifier at full power) for a total of 10 min. The 
sonication was carried out at 1 min intervals so that 
the temperature of the bacterial suspension did not rise 
above 10 C. The material was then centrifuged at 
18,000 G for 30 min, and the supernate, which con-
tained the hemolysin, was removed and frozen at 
- 20 C until further steps could be carried out. 
Preliminary studies using step-wise fractionation 
disclosed that the hemolysin was precipitated from the 
bacterial liquor between 20 and 60% saturation with 
ammonium sulfate. All subsequent preparations of the 
hemolysin were made with the precipitate formed 
between these two concentrations of this salt. The 
precipitate was dissolved in distilled water and dialyzed 
against cold distilled water until the dialysis bath no 
longer reacted with Nessler's reagent. The dialyzed 
material was then divided into aliquots, freeze-dried, 
vacuum sealed and stored at - 20 C until further use. 
The hemolytic activity of this extract varied from 
batch to batch; ordinarily it required 0.006 to .01 ml 
of the material (equivalent to 87-145 µ.g of protein) 
to completely lyse 1 ml of human or rabbit erythro-
cytes. In its freeze-dried state the hemolysin maintained 
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its potency for at least 5 years. When it was stored in 
solution at room temperature for 8 days, there was a 
four-fold reduction in its hemolytic activity; when 
stored in solution at -20 C for 12 months, there was 
a 16-fold reduction in its activity. In the latter instance, 
part of its activity could be restored by the addition of 
0.4 M cysteine. 
Hemolysin Assay 
Maximal lysis of either human or rabbit erythrocytes 
by the hemolysin occurred within 60 min at 37 C. 
Two methods of quantitation were used for the studies 
to be reported here. The first involved the addition 
of 0.5 ml of a known dilution of the hemolysin to 1 ml 
of a 50% suspension of thrice washed rabbit or human 
erythrocytes in isotonic sodium chloride solution; this 
mixture was incubated for 60 min at 37 C, centrifuged 
at 3000 G for 5· min, and the amount of hemoglobin 
released into the supernatant solution was measured 
spectrophotometrically. Results were expressed as per-
centage of red cells lysed. This method was satis-
factory for much of the early work where gross 
differences of hemolysis were evident, but when dif-
ferences were more subtle, a more sensitive method of 
assay was needed. 
For this latter purpose, serial dilutions of the 
hemolysin were made in 0.85% sodium chloride so-
lution. One ml of a 3 % suspension of thrice washed 
human or rabbit erythrocytes in isotonic saline was 
added to an equal volume of each dilution of hemoly-
sin. The tubes containing these mixtures were mixed 
thoroughly and incubated for 60 min at 37 C. After 
incubation, the contents of the tubes were mixed 
again, centrifuged at 2000 G for 2 min, and the 
degree of hemolysis graded on a scale of from 0 to 
4+ (complete hemolysis). Results using this method 
were reproducible within one tube dilution. 
Hemolysin Inhibition Titer 
Two-fold serial dilutions of the serum under investi-
gation were made using 0.85% sodium chloride as dilu-
ent. Five-tenths milliliter of each serum dilution was 
mixed with 0.5 ml of diluted hemolysin; the concen-
tration of hemolysin used was one tube dilution less 
than that dilution which produced complete lysis of 
the standard red cell suspension. After the mixtures of 
serum and hemolysin had been incubated at 37 C for 
15 min, 1 ml of a 3% suspension of washed rabbit 
erythrocytes was added to each tube. The contents of 
the tubes were thoroughly mixed, incubated at 37 C 
for 60 min, centrifuged at 3000 G for 2 min, and 
examined for hemolysis. The highest dilution of 
serum which completely inhibited hemolysis under 
these conditions was termed the "hemolysin inhibition 
titer." Results were reproducible from day to day 
within two tube dilutions, but whenever two or more 
sera were compared they were analyzed simultaneously. 
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TABLE I 
Effect of Trypsin on Pneumococcal Hemolysin 
Hemolysin Dilution Trypsin-Percent Percent Hemolysis 
1 : 200 
1: 200 
1: 200 
0 
0 
0 
.0009 
.009 
.0009 
.009 
94 
85 
2 
1 
1 
Crystalline trypsin was dissolved in M/ 15 phosphate 
buffer pH 7.3 and mixed with the crude bacterial 
extract (hemolysin) so that final concentrations were 
as above. Control tubes contained isotonic saline solu-
tion. After 30 min at 37 C, 0.5 ml of each mixture 
was added to 1 ml of 50% suspension of washed 
rabbit erythrocytes, tubes mixed arid incubated at 37 C 
for 60 min and centrifuged. Percentage of cells lysed 
was measured spectrophotometrically. 
TABLE II 
Effect of Cholesterol on Pneumococcal Hemolysin 
Cholesterol 
Hemolysin Dilution mg/ 100 ml Percent hemolysis 
1: 200 0 93 
1: 200 90 < 
1 : 200 9 < 
0 90 < 
0 9 < 
Cholesterol suspended in isotonic sodium chloride 
solution was mixed with bacterial extract (hemolysin) 
to give final concentrations noted above. Control tubes 
contained isotonic saline solution. After 30 min at 
37 C, 0.5 ml of each mixture was added to 1 ml of 
a 50% suspension of washed rabbit erythrocytes in 
isotonic sodium chloride. Tubes were mixed thor-
oughly, incubated 60 min at 37 C and centrifuged. 
Percentage of cells lysed was measured spectrophoto-
metrically. 
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As an additional control, at the time of each assay 
a "standard serum" of known inhibitory effect was also 
analyzed; these results were always within one tube 
dilution. 
The animals used for in vivo studies were mature 
male albino rabbits. Blood was obtained from mar-
ginal ear veins and measurements of packed red cell 
volume and erythrocyte osmotic fragility were made 
by standard methods (Shumway and Pollock, 1965). 
The degree of hemoglobinemia was estimated qualita-
tively by inspection of supernatant plasma. 
Results 
The hemolysin present in this bacterial extract ex-
hibited characteristics similar to those described by 
others working with "pneumococcal hemolysin," 
"pneumotoxin," or "pneumococcus hemotoxin" 
(Cohen, Halbert and Perkins, 1942; Cole, 1914; 
Cowan, 1934; Fleming and Neill, 1927; Halbert, 
Cohen and Perkins, 1946; Neill, 1926; Weiss, 1918). 
Hemolytic activity was abolished by heating to 56 C 
for 10 min and by exposure of the hemolysin to 
trypsin (Table I) or cholesterol (Table II) . 
Sodium cyanide 0.02m and disodium-EDTA 0.003m 
exhibited no inhibitory effects. Normal human sera 
and normal rabbits' sera exhibited slight inhibitory 
effect, the former more than the latter. 
The effect of temperature upon the interaction of 
hemolysin and erythrocytes was noteworthy. When 
hemolysin and either human or rabbit red blood cells 
were incubated together for 60 min at temperatures 
between 4 C and 37 C, the 'degree of hemolysis was 
greater at the higher temperatures (Fig 1), At 4 C 
hemolysis was virtually absent. When erythrocytes 
which had been exposed to hemolysin for 60 min at 
4 C were washed three times with 10 volumes of 
cold isotonic saline solution, resuspended to their 
original volume and incubated at 37 C for 60 min, 
lysis occurred. The supernatant material from the 
original mixture of hemolysin and erythrocytes failed 
to lyse fresh erythrocytes when exposed to them at 37 
C for 60 min. 
Earlier studies had shown that the intravenous ad-
ministration of supernatant broth from a culture of 
Diplococcus pneumoniae to rabbits resulted in intra-
vascular hemolysis (Shumway and Pollock, 1965). As 
will be demonstrated, this same phenomenon was 
observed after injection of crude bacterial extract. Be-
cause the characteristics of the hemolysin suggested 
that it was a protein or contained protein as an 
integral part of its structure, it was likely to be 
antigenic. The results of the following experiments 
are compatible with this hypothesis. 
Normal mature male albino rabbits were selected at 
random. Blood samples were obtained for baseline 
measurements of red blood cell morphology, packed 
red cell volume and erythrocyte osmotic fragility; an 
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Fig I-Effect of temperature upon the lysis of human 
erythrocytes by pneumococcal hemolysin. 
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aliquot of serum was frozen for subsequent determi-
nation of the "hemolysin inhibition titer." A standard 
amount of the crude bacterial hemolysin (0.2 ml/kg) 
diluted in isotonic sodium chloride solution was given 
intravenously to each rabbit, and 2 hr later a sec-
ond blood sample was obtained to reassess the 
above mentioned parameters. 
The results are summarized in Table III. Twelve of 
22 rabbits exhibited unequivocal evidence of intra-
vascular hemolysis as manifested by a 6% or greater 
decrease in packed red cell volume, an increase of 
erythrocyte osmotic fragility and hemoglobinemia. The 
animals' erythrocytes were found to be spherocytic or 
to have a crenated or spiculated appearance (Fig 2). 
Abnormalities of at least one or two of these param-
eters were evident in nine other animals. The one 
rabbit which failed to exhibit any evidence of hemoly-
sis was subsequently found to have a high "hemolysin 
inhibition titer" (1/ 5120) without any known prior 
exposure to the hemolysin. 
Nine of the rabbits which had been challenged by 
the intravenous injection of the hemolysin were given 
"booster doses" of the material (one-fourth original 
amount) intramuscularly, 9, 12, and 14 days after 
the original challenge. On the 21st day the sera of 
seven of the nine animals had an increased ability to 
inhibit the hemolysin in vitro; the "hemolysin in-
hibition titers" rose from 1/80 or less to values from 
1/640 to 1/ 5120. When these immunized rabbits were 
challenged a second time by the intravenous injection 
of the standard amount of hemolysin, none exhibited 
any evidence of intra vascular hemolysis (Fig 3; 
Table III). 
Fig 2-Photomicrographs of rabbit's blood smear (Wright Stain) . (A) Normal rabbit. (B) Same animal 2 hr after in-
travenous administration of pneumococcal hemolysin. Note presence of spherocytes and "spiculated" erythrocytes. 
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TABLE III 
Effects of Administration of Pneumococcal Hemolysin to Normal and Immunized Rabbits 
SECOND INJECTION OF PNEUMOCOCCAL 
FIRST INJECTION OF PNEUMOCOCCAL HEMOLYSIN HEMOLYSIN 
Increase of** Increase of 
Hemolysin Change in* Erythrocyte Hemolysin Change in Erythrocyte 
Rabbit Inhibition PCV Osmotic Inhibition PCV Osmotic 
No. Titer % Fragility Hemoglobinemia Titer % Fragility Hemoglobinemia 
127 1/ 10 -13 + + 
128 1/ 10 -17 + + 
130 1/ 20 -5 0 + 
133 < 1/ 10 -1 0 + 
141 1/ 80 -3 + + 
142 1/ 160 -3 0 + 
147 1/ 5120 -4 0 0 
151 <1/10 -23 + + 
152 < 1/ 10 -25 + + 
183 1/ 40 -2 0 + 
184 <1 / 10 0 + + 
185 1/ 10 - 11 + + 
. 186 < 1/ 10 - 14 + + 
129 1/ 10 -4 + + 1/ 640 0 0 0 
131 1/ 20 -10 + + 1 / 1280 +2 0 0 
132 <1 / 10 -18 + + 1/1280 -3 0 0 
134 < 1/ 10 -13 + + 1 / 1280 - 3 0 0 
144 1/ 80 - 11 + + 1/80 +6 0 0 
145 <1 / 10 -5 0 + >1 / 5120 - 1 0 0 
146 < l/10 - 3 0 + 1/ 2560 - 3 0 0 
153 1/80 -7 + + 1/ 80 -5 0 0 
157 1/ 40 -7 + + 1/ 640 +2 0 0 
* Packed red cell volume (hematocrit) 
* + Denotes an increase beyond two standard deviations of normal mean 
A surprising phenomenon was noted in five of six 
rabbits that were studied in more detail. On the first 
and second day after the first intravenous injection of 
the bacterial product, the animals' "hemolysin inhi-
bition titer" rose transiently, but by the fifth day the 
results returned to the previous low values. Coincident 
with the transient rise 'in "inhibition titer" these sera 
appeared opalescent as if hyperlipemic. 
Discussion 
Libman ( 1905) is credited with first describing the 
lysis of erythrocytes by Diplococcus pneumoniae. Nine 
years later Cole ( 1914) prepared an extract of 
pneumococcal cell bodies which lysed human, rabbit, 
sheep, and guinae pig erythrocytes. He noted that 
the hemolysin was inactivated by trypsin, cholesterol, 
heat (55 C for 30 min), and by the sera of animals 
which had been immunized with the material. 
From 1914 to 1946 many investigators (Cohen, 
Halbert and Perkins, 1942; Cole, 1914; Cowan, 1934; 
Fleming and Neill, 1927; Halbert, Cohen and Perkins, 
1946; Neill, 1926; Weiss, 1918) working with crude 
bacterial cell extracts studied the properties of the 
hemolysin and arrived at the following conclusions : 
The substance responsible for the hemolytic property 
of the pneumococcus is present within the bacterial 
cells, and under some conditions it is elaborated 
into the culture medium. The hemolysin is heat 
labile (56 C for 3 min) and is inactivated by trypsin, 
cholesterol, red blood cell stroma, and oxidizing 
agents. Oxidation by air and mild chemical oxidants 
is partially reversed by reducing agents. Halbert, 
Cohen and Perkins (1946) produced evidence which 
suggested that the hemolysin also exhibited dermotoxic 
and lethal toxicity. Recently, Kreger and Bernheimer 
( 1969) found that the hemolysin behaved as an 
acidic protein with an isoelectric pH of 4.9 apd a 
molecular weight of approximately 63,000. In some 
respects it is thought to resemble streptolysin O; Todd 
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( 1934) demonstrated that the sera from animals 
:immunized with streptolysin 0 partially inhibited 
'pneumococcal hemolysin. However, Tunevall (1953) 
noted that in human infections there was no significant 
;neutralization of "pneumolysin" by antistreptolysin 
immune sera or of streptolysin 0 by "antipneumolysin" 
sera. 
A great deal of effort was expended to determine 
the role, if any, which the hemolysin played in the 
pathogenesis of pneumococcal infections. All investi-
gators who administered the material to experimental 
animals commented upon the absence of demonstrable 
hemolysis in vivo. Although it has not been shown that 
this substance plays a significant part in the disease 
process, this possibility has not been excluded. 
With the advent of chemotherapeutic agents and 
antibiotics, interest in Diplococcus pneumoniae waned. 
In 1958 it was noted that pneumococcal septicemia in 
rabbits was associated with a spherocytic hemolytic 
anemia. (Shumway, 1958) Later it was found that 
,the intravenous administration to rabbits of super-
natant broth from cultures of Diplococcus pneumoniae, 
type l, resulted in spherocytosis, increased erythrocyte 
osmotic fragility and intravascular hemolysis (Shum-
way and Pollock, 1965). This observation suggested 
that pneumococcal septicemia of rabbits might offer a 
model in which to test the hypothesis that this bac-
A 
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terial hemolysin plays a role in the . pathogenesis of 
pneumococcal infections. The studies reported here 
represent a step toward this goal. 
The results of these studies demonstrate that a 
crude extract of Diplococcus pneumoniae, type 1 cells, 
damages and lyses human and rabbit erythrocytes in 
vitro and rabbit erythrocytes in vivo. The character-
istics of our material suggest that it contains the same 
products which other workers have described as 
"pneumolysin," "pneumococcal hemolysin," "pneumo-
coccal hemotoxin" and "pneumotoxin." The observa-
tion that the sera of rabbits which have received mul-
tiple injections of the material are able to neutralize 
the hemolysin in vitro, suggests that the material is 
antigenic. This suggestion is strengthened by the 
demonstration that an immunized rabbit does not 
experience hemolysis when challenged by an intrave-
nous injection of the active hemolysin. 
Although the term "hemolysin" has been used 
to describe this bacterial product, the term should not 
be taken literally. Halbert, Cohen and Perkins ( 1946) 
presented evidence which suggested that the material 
was lethal to mice and dermotoxic to guinea pigs. 
Robert Post working with our crude material has 
demonstrated that it damages and destroys human 
A V3 cells in tissue culture, and that this cytotoxic 
effect is abolished by heating the bacterial extract for 
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Fig 3-Effect of administration of pneumococcal hemolysin to a normal rabbit (A); and to same immunized animal 
(B) 21 days later. Shaded area represents the normal range (± 2 SD) of erythrocyte osmotic fragility. Measurements 
made 2 hr after injection of the hemolysin. 
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10 min at 56 Corby prior mixing of the extract with 
serum of an immunized rabbit. Thus, the "hemolysin" 
may have an affinity for and effect upon many cells 
including the erythrocyte. 
The major weakness of this study and the work of 
others is the heterogeneity of the bacterial product. It 
is truly a crude extract; analytical disc gel electro-
phoresis of the material discloses the presence of many 
bands of protein. Before the question of its signif-
icance in the pathogenesis of pneumococcal infections 
can be answered and before its mechanism of action 
can be determined, a purified preparation must be 
obtained. 
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